SARS-CoV-2 (COVID-19) Full-Length Gamma Variant (P.1, Brazil) Spike Recombinant Protein
1337.54 €
In Stock
quantity
product details
Catalog number: 223 - 21-820
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 0.025 mg
BSV-COV-PR-69
SARS-CoV-2 full-length Trimeric Spike Antigen (Brazil Variant, 100ug)
SARS-CoV-2 full-length Trimeric Spike Antigen (Brazil Variant, 100ug)
1090.80 €
BSV-COV-PR-71
SARS-CoV-2 full-length Trimeric Spike Antigen (Brazil Variant, 1mg)
SARS-CoV-2 full-length Trimeric Spike Antigen (Brazil Variant, 1mg)
5896.38 €
BSV-COV-PR-90
SARS-CoV-2 full-length Trimeric Spike Antigen (Brazil Variant, 10mg)
SARS-CoV-2 full-length Trimeric Spike Antigen (Brazil Variant, 10mg)
23131.02 €
21-805
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein
SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells.
841.23 €
21-807
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein
SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells.The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) is used as antigen in the Serological ELISA Kit to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma (see SARS-CoV-2 (Spike RBD) IgG Serological ELISA Kit; AG-45B-0020).